MULTIVESSEL DISEASE AS A PROGNOSTIC MARKER IN PATIENTS PRESENTING FOR PRIMARY PERCUTANEOUS CORONARY INTERVENTION

Mahesh Kumar Batra, Syed Ishtiaq Rasool, Bashir Ahmed Solangi, Naveedullah Khan, Musa Karim, Syed Nadeem Hassan Rizvi

Abstract


Background: Multi-vessel disease is associated with higher mortality rates in ST-Elevation Myocardial Infarction (STEMI) patients, which may further alter clinical course and decision making. Hence, the purpose of this study is to determine prevalence, in hospital and early after discharge (up to 30 days) outcome of patients with multi-vessel disease as compared to single vessel disease presenting with acute STEMI undergoing Primary PCI. Methods: This study includes 282 consecutive selected patients, presented in emergency department with acute STEMI; undergo primary percutaneous coronary intervention (PCI) at Catheterization Laboratory of National Institute of Cardiovascular Diseases (NICVD), Karachi Pakistan during the study period of 17th December 2016 to 16th June 2017. Demographic characteristics, clinical history, post procedural complications, and short term adverse clinical events in patients with SVD and MVD were assessed and compared using z-test, t-test, and Fisher's Exact test. Results: Comparing the patients with single vessel disease, multi-vessel disease patients have worse post procedural outcomes, increased overall complications, length of hospital stay, higher referral for CABG, and in-hospital mortality. On follow up relatively higher, but not statistically significant, patient with MVD developed recurrence of symptoms and got re-admission. Conclusion: Multi-vessel disease in patients presenting for primary PCI is the direct indicative of significantly higher post procedure complications, mortality, morbidity, and prolonged hospitalization. Also, risk of recurrence of symptoms and re-admission remains high in patients with multi-vessel disease.

Keywords: Multi-vessel disease; Primary percutaneous coronary intervention, PCI; ST-Elevation Myocardial Infarction, STEMI


Full Text:

PDF

References


Ahuja YR, Sharma S, Mohan V. Cardiovascular diseases: interplay of epigenetics. Clin Exp Hypertens 2017;39(1):1–7.

Karamfiloff KK, Stoykova ZD, Georeva PG, Trendafilova DK, Jorgova JB. Multivessel disease as a prognostic factor for mortality in STEMI patients. J Biomed Clin Res 2015;8(1):30–4.

Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35(37):2541–619.

Deharo P, Strange JW, Mozid A. Primary percutaneous coronary intervention of native chronic total occlusions to treat ST elevation myocardial infarction secondary to acute vein graft occlusion. Catheter Cardiovasc Interv 2017;90(2):251–6.

Weissler-Snir A, Gurevitz C, Assali A, Vaknin-Assa H, Bental T, Lador A, et al. Prognosis of STEMI patients with multi-vessel disease undergoing culprit-only PCI without significant residual ischemia on non-invasive stress testing. PloS One 2015;10(9):e0138474.

Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007;28(14):1709–16.

Corpus RA, House JA, Marso SP, Grantham JA, Huber KC, Laster SB, et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 2004;148(3):493–500.

Widimsky P, Holmes DR Jr. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?. Eur Heart J 2010;32(4):396–403.

Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol 2009;104(4):507–13.

De Luca G, Parodi G, Sciagrà R, Bellandi B, Comito V, Vergara R, et al. Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty. Atherosclerosis 2014;234(1):244–8.

Tarantini G, Napodano M, Gasparetto N, Favaretto E, Marra MP, Cacciavillani L, et al. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty. Coron Artery Dis 2010;21(2):78–86.

Steg G, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33(20):2569–619.

Toma A, Stähli BE, Gick M, Gebhard C, Nührenberg T, Mashayekhi K, et al. Impact of multi-vessel versus single-vessel disease on outcomes after percutaneous coronary interventions for chronic total occlusions. Clin Res Cardiol 2017;106(6):428–35.

de Waha S, Eitel I, Desch S, Fuernau G, Pöss J, Schuler G, et al. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial. Eur Heart J Acute Cardiovasc Care 2015;6(7):592–600.

Lekston A, Tajstra M, Gąsior M, Gierlotka M, Pres D, Hudzik B, et al. Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. Kardiol Pol 2011;69(4):336–43.

Lekston A, Hudzik B, Szkodziński J, Gąsior M, Tajstra M, Kalarus Z, et al. Spontaneous reperfusion before intervention improves immediate but not long-term prognosis in diabetic patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease. Cardiol J 2013;20(4):378–84.

van der Schaaf RJ, Timmer JR, Ottervanger JP, Hoorntje JC, de Boer MJ, Suryaparanata H, et al. Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart 2006;92(12):1760–3.

Bainey KR, Mehta SR, Lai T, Welsh RC. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. ‎Am Heart J 2014;167(1):1–14.

Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 2015;65(10):963–72.

Rasoul S, Van Ommen V, Vainer J, Ilhan M, Veenstra L, Erdem R, et al. Multivessel revascularisation versus infarct-related artery only revascularisation during the index primary PCI in STEMI patients with multivessel disease: a meta-analysis. Neth Heart J 2015;23(4):224–31.

Li Z, Zhou Y, Xu Q, Chen X. Staged versus one-time complete revascularization with percutaneous coronary intervention in STEMI patients with multivessel disease: a systematic review and meta-analysis. PloS One 2017;12(1):e0169406.


Refbacks

  • There are currently no refbacks.


Contact Number: +92-992-382571

email: [jamc] [@] [ayubmed.edu.pk]